ESC 365 - Oral anticoagulant use and outcomes in Asian patients with atrial fibrillation in the GLORIA-AF Registry

ESC Professional Premium Access

Oral anticoagulant use and outcomes in Asian patients with atrial fibrillation in the GLORIA-AF Registry

Session: Risks and effects of interventions on prognosis and outcome in atrial fibrillation

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor G. Romiti (Rome, IT)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Giulio Francesco Romiti

Sapienza University of Rome, Rome (Italy)

4 presentations

2 followers

5 more presentations in this session

Risk of incident atrial fibrillation and subsequent use of oral anticoagulants in patients with dementia

Speaker: Doctor T. Chao (Taipei, TW)

Amiodarone is associated with increased mortality compared with other antiarrhythmic drugs in female patients with atrial fibrillation

Speaker: Professor J. Choi (Seoul, KR)

AF in the AFternoon: The circadian pattern of incident atrial fibrillation in a loop recorder population

Speaker: Doctor P. Chousou (Cambridge, GB)

Associations of adding salt to foods with incident atrial fibrillation in the UK biobank study

Speaker: Doctor Y. Park (Daegu, KR)

Risk of atrial tachycardias after covid-19: nationwide self-controlled cases series and matched cohort study.

Speaker: Doctor I. Katsoularis (Umea, SE)

Access the full session

Risks and effects of interventions on prognosis and outcome in atrial fibrillation

Speakers: Doctor G. Romiti, Doctor T. Chao, Professor J. Choi, Doctor P. Chousou, Doctor Y. Park...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources